Effect of Antihypertensive Program on the Prevention and Treatment of Cerebral Small Vessel Disease
-
摘要: 2017年,美国心脏病学会和美国心脏协会提出将高血压诊断标准降为130/80 mm Hg(1 mm Hg=0.133 kPa),这与其他指南有所不同。降压治疗的核心目标在于靶器官的保护,近年来降压治疗与脑小血管病预防的相关问题日益受到临床重视。目前研究结果表明, 降压治疗对腔隙性卒中患者的二级预防以及白质病变进展的预防可能有一定积极意义,但确切的降压目标值并未确定。血压与临床结局可能呈现J型关系,血压过低或过高可能均有害,而取得最大获益的降压目标有待进一步探索。Abstract: Recently, ACC/AHA has proposed the new diagnostic criteria of hypertension as130/80 mm Hg (1 mm Hg=0.133 kPa), which is different from other guidelines. The core goal of antihypertensive therapy is the protection of target organs. Therefore, the issues related to intensive antihypertensive therapy and the prevention of cerebral small vessel disease have attracted more attention in recent years. Current findings suggest that the antihypertensive program may have a positive effect on secondary prevention of lacunar stroke and white matter lesions. The exact target blood pressure (BP) has not been determined yet. BP and clinical outcomes may present a J-type relationship, indicating that too low or too high BP may both be harmful, and the ideal target BP is to be further explored.
-
Key words:
- hypertension /
- cerebral small vessel disease /
- lacunar stroke /
- white matter lesion
利益冲突 无 -
[1] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/ AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2018, 138:e426-e483. https://pubmed.ncbi.nlm.nih.gov/29146533/ [2] James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)[J]. JAMA, 2014, 311:507-520. doi: 10.1001/jama.2013.284427 [3] Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension[J]. J Hypertens, 2018, 36:1953-2041. doi: 10.1097/HJH.0000000000001940 [4] Pantoni L.Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges[J]. Lancet Neurol, 2010, 9: 689-701. doi: 10.1016/S1474-4422(10)70104-6 [5] Wardlaw JM, Smith EE, Biessels GJ, et al.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration[J]. Lancet Neurol, 2013, 12: 822-838. doi: 10.1016/S1474-4422(13)70124-8 [6] Yakushiji Y, Charidimou A, Noguchi T, et al. Total Small Vessel Disease Score in Neurologically Healthy Japanese Adults in the Kashima Scan Study[J].Intern Med, 2018, 57:189-196. doi: 10.2169/internalmedicine.8393-16 [7] Heye AK, Thrippleton MJ, Chappell FM, et al. Blood pressure and sodium: Association with MRI markers in cerebral small vessel disease[J].J Cereb Blood Flow Metab, 2016, 36:264-274. doi: 10.1038/jcbfm.2015.64 [8] Verhaaren BF, Vernooij MW, de Boer R, et al. High blood pressure and cerebral white matter lesion progression in the general population[J]. Hypertension, 2013, 61:1354-1359. doi: 10.1161/HYPERTENSIONAHA.111.00430 [9] Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline[J].Neurology, 2011, 77:461-468. doi: 10.1212/WNL.0b013e318227b227 [10] de Leeuw FE, de Groot JC, Oudkerk M, et al. A follow-up study of blood pressure and cerebral white matter lesions[J]. Ann Neurol, 1999, 46:827-833. doi: 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO;2-H [11] Campbell P, Ghuman N, Wakefield D, et al. Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly[J].J Hum Hypertens, 2010, 24:749-754. doi: 10.1038/jhh.2010.8 [12] Klarenbeek P, van Oostenbrugge RJ, Rouhl RP, et al. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease[J].Stroke, 2013, 44:2995-2999. doi: 10.1161/STROKEAHA.113.002545 [13] Yan B, Peng L, Dong Q, et al. Reverse-dipper pattern of blood pressure may predict lacunar infarction in patients with essential hypertension[J].Eur J Neurol, 2015, 22:1022-1025. doi: 10.1111/ene.12659 [14] ACCORD Study Group, Cushman WC, Evans GW, et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus[J].N Engl J Med, 2010, 362:1575-1585. doi: 10.1056/NEJMoa1001286 [15] SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control[J].N Engl J Med, 2015, 373:2103-2116. doi: 10.1056/NEJMoa1511939 [16] SPS3 Study Group, Benavente OR, Coffey CS, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial[J].Lancet, 2013, 382: 507-515. doi: 10.1016/S0140-6736(13)60852-1 [17] Hart RG, Pearce LA, Bakheet MF, et al. Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial[J].J Stroke Cerebrovasc Dis, 2014, 23:618-624. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.021 [18] Odden MC, McClure LA, Sawaya BP, et al. Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial[J].Hypertension, 2016, 67:63-69. doi: 10.1161/HYPERTENSIONAHA.115.06480 [19] White WB, Marfatia R, Schmidt J, et al. INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY)[J].Am Heart J, 2013, 165:258-265, e1. doi: 10.1016/j.ahj.2012.11.008 [20] Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy[J].Circulation, 2005, 112:1644-1650. doi: 10.1161/CIRCULATIONAHA.104.501163 [21] Firbank MJ, Wiseman RM, Burton EJ, et al. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure[J].J Neurol, 2007, 254:713-721. doi: 10.1007/s00415-006-0238-4 [22] Williamson JD, Launer LJ, Bryan RN, et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial[J]. JAMA Intern Med, 2014, 174:324-333. doi: 10.1001/jamainternmed.2013.13656 [23] Supiano MA. Benefit-based approach to blood pressure control in older adults[J].J Am Geriatr Soc, 2015, 63:730-732. doi: 10.1111/jgs.13341 [24] Ovbiagele B, Diener HC, Yusuf S, et al. Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke[J].JAMA, 2011, 306:2137-2144. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=068996fe549316ff842002c89fe4cb76 [25] Ovbiagele B. Low-normal systolic blood pressure and secondary stroke risk[J].J Stroke Cerebrovasc Dis, 2013, 22:633-638. doi: 10.1016/j.jstrokecerebrovasdis.2011.12.003 [26] Ku E, Scherzer R, Odden MC, et al. Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial[J]. Blood Press, 2017, 27:73-81.
点击查看大图
计量
- 文章访问数: 402
- HTML全文浏览量: 24
- PDF下载量: 203
- 被引次数: 0